Long-Acting Cabotegravir/Rilpivirine, Lenacapavir, and Ibalizumab Use Among Persons With HIV-1 Viremia at a Ryan White-Funded Clinic in the Urban US South
- DOI
- 10.1093/cid/ciaf425
- Published
- 2025-08-01
- Container
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/cid/ciaf425,
title = {Long-Acting Cabotegravir/Rilpivirine, Lenacapavir, and Ibalizumab Use Among Persons With HIV-1 Viremia at a Ryan White-Funded Clinic in the Urban US South},
author = {Jonathan A Colasanti and Amalia Aldredge and Larisa V Niles-Carnes and Eudiah Ochieng and Priyasha Pareek and Vickie Robinson and Erica Anderson and Mary Castaneda and Hilary Spralling and Bradley L Smith and Jeri Sumitani and Eric Paul Leue and Caitlin A Moran and Meredith Lora and Wendy S Armstrong and Lauren F Collins},
year = {2025},
journal = {Clinical Infectious Diseases},
doi = {10.1093/cid/ciaf425},
url = {https://doi.org/10.1093/cid/ciaf425}
}RIS
TY - JOUR TI - Long-Acting Cabotegravir/Rilpivirine, Lenacapavir, and Ibalizumab Use Among Persons With HIV-1 Viremia at a Ryan White-Funded Clinic in the Urban US South AU - Jonathan A Colasanti AU - Amalia Aldredge AU - Larisa V Niles-Carnes AU - Eudiah Ochieng AU - Priyasha Pareek AU - Vickie Robinson AU - Erica Anderson AU - Mary Castaneda AU - Hilary Spralling AU - Bradley L Smith AU - Jeri Sumitani AU - Eric Paul Leue AU - Caitlin A Moran AU - Meredith Lora AU - Wendy S Armstrong AU - Lauren F Collins PY - 2025 JO - Clinical Infectious Diseases DO - 10.1093/cid/ciaf425 UR - https://doi.org/10.1093/cid/ciaf425 ER -
APA
Colasanti, J. A., Aldredge, A., Niles-Carnes, L. V., Ochieng, E., Pareek, P., Robinson, V., Anderson, E., Castaneda, M., Spralling, H., Smith, B. L., Sumitani, J., Leue, E. P., Moran, C. A., Lora, M., Armstrong, W. S., & Collins, L. F. (2025). Long-Acting Cabotegravir/Rilpivirine, Lenacapavir, and Ibalizumab Use Among Persons With HIV-1 Viremia at a Ryan White-Funded Clinic in the Urban US South. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf425
Source records
- crossref · retrieved 2026-09-26T04:39:43.676Z